9 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Company News for Feb 16, 2024 https://www.zacks.com/stock/news/2227473/company-news-for-feb-16-2024?cid=CS-ZC-FT-corporate_summary-2227473 Feb 16, 2024 - Companies in The News Are:HBI,WEN,ET,CF
CF (CF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2226492/cf-cf-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2226492 Feb 14, 2024 - While the top- and bottom-line numbers for CF (CF) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Insights Into CF (CF) Q4: Wall Street Projections for Key Metrics https://www.zacks.com/stock/news/2224005/insights-into-cf-cf-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224005 Feb 09, 2024 - Evaluate the expected performance of CF (CF) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Vertex to seek FDA, EMA approval for CF therapy by mid-2024 https://seekingalpha.com/news/4062897-vertex-to-seek-fda-ema-approval-for-vanza-triple-therapy-for-cf?source=feed_sector_healthcare Feb 05, 2024 - Vertex Pharmaceuticals (VRTX) reported positive Phase 3 study results for its vanza triple therapy in the treatment of cystic fibrosis and plans to seek US and
4D Molecular gets FDA rare pediatric disease status for CF drug https://seekingalpha.com/news/4057428-4d-molecular-gets-fda-rare-pediatric-disease-status-for-cf-drug?source=feed_sector_healthcare Jan 23, 2024 - 4D Molecular Therapeutics (FDMT) has received FDA rare pediatric disease designation for its cystic fibrosis drug candidate 4D-710. Read more here.
Focus on These 4 Low P/CF Stocks to Maximize Returns in 2024 https://www.zacks.com/stock/news/2214329/focus-on-these-4-low-p-cf-stocks-to-maximize-returns-in-2024?cid=CS-ZC-FT-analyst_blog|rw-2214329 Jan 23, 2024 - Value investing is essentially about selecting stocks that are cheap but fundamentally sound. PVH Corp. (PVH), Centene (CNC), General Motors (GM) and Graphic Packaging (GPK) boast a low P/CF ratio.
Zacks Industry Outlook Highlights CF Industries and ICL https://www.zacks.com/stock/news/2206869/zacks-industry-outlook-highlights-cf-industries-and-icl?cid=CS-ZC-FT-press_releases-2206869 Jan 08, 2024 - CF Industries and ICL are part of the Zacks Industry Outlook article.
2 Fertilizer Stocks to Watch Amid Industry Headwinds https://www.zacks.com/commentary/2206027/2-fertilizer-stocks-to-watch-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2206027 Jan 05, 2024 - A pullback in fertilizer prices on softer demand and elevated costs of key raw materials pose headwinds for the Zacks Fertilizers industry. CF and ICL are poised well to tackle the challenges.
Add Value to Your Investment With These 4 Low P/CF Stocks https://www.zacks.com/stock/news/2192829/add-value-to-your-investment-with-these-4-low-p-cf-stocks?cid=CS-ZC-FT-analyst_blog|rw-2192829 Dec 04, 2023 - Value investing is essentially about selecting stocks that are cheap but fundamentally sound. PVH Corp. (PVH), Centene (CNC), Solo Brands (DTC) and Park Hotels & Resorts (PK) boast a low P/CF ratio.

Pages: 1

Page 1